BioStem Technologies’ CEO and COO invest $1M in cash through exercise of stock options
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
PepsiCo cuts its full-year profit forecast to 2.5%-3.5% growth as North America drags
The snacks and beverages company beat quarterly estimates but slashed its core EPS growth outlook from a prior target of 5% to 7%
Not SpaceX. Not Blue Origin. The Space Titan That Morgan Stanley Calls an Undervalued Launch Play.
Key PointsRocket Lab is winning launch contracts and was called underrated by Morgan Stanley.
Ringgit ends higher against Asean currencies, lower versus US dollar
KUALA LUMPUR: The ringgit closed higher on Thursday against most Asean currencies, but lower against the US dollar amid a renewed surge in oil prices and escalating geopolitical tensions in Middle…
Downstreaming drives 30 percent of national investment: Danantara
Indonesia’s downstream sector accounted for 30 percent of total national investment realization in the first ...
OPR hikes will dampen consumer sentiment, share prices
An interest rate hike in 2027 will be a headwind for consumer spending and stocks, says Kenanga Investment Bank.